VAV Life Sciences is ramping up the production of the crucial lipid ingredients used in Liposomal Amphotericin B, the drug used to treat mucormycosis (black fungus) infections. It is the only domestic firm that produces the highly purified synthetic phospholipids needed for producing Liposomal Amphotericin B.